INKT

MiNK Therapeutics, Inc.$10.70+0.17 (+1.61%)

Prev Close$10.53·MCap$55.3M·P/E—·Vol4.8K·Yield—

▲

Buys (12M)

$0.00

▼

Sells (12M)

$106.7K

◆

Net Activity

Net Seller

$106.7K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at MiNK Therapeutics, Inc. (INKT) has been exclusively selling, with 0 insider purchases totaling $0.00 and 3 insider sales totaling $106.7K. The most recent insider transaction was by Buell Jennifer (director, officer: Chief Executive Officer), who sold $73.3K worth of shares on Oct 14, 2026. MiNK Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $55.3M.

INKT Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Oct 14, 2026	Buell Jennifer	director, officer: Chief Executive Officer	Sell	6,938	$10.56	$73.3K	74,195
Jun 5, 2026	Ryan Barbara	director	Sell	1,500	$12.76	$19.1K	22,969
Mar 11, 2026	Ryan Barbara	director	Sell	1,000	$14.27	$14.3K	21,706
Oct 16, 2023	AGENUS INC		Buy	22,975	$1.10	$25.3K	21,772,864
Oct 6, 2023	AGENUS INC		Buy	15,001	$1.09	$16.4K	21,749,888
Aug 31, 2023	AGENUS INC		Buy	29,678	$1.52	$45.0K0.6% OS	21,734,888
Aug 28, 2023	AGENUS INC	10% Owner	Buy	183,052	$1.54	$281.5K3.9% OS	21,705,208
May 12, 2023	AGENUS INC		Buy	45,426	$1.47	$66.6K1.0% OS	21,640,472
May 5, 2023	AGENUS INC		Buy	250,362	$1.04	$260.2K5.3% OS	21,595,048
May 5, 2023	ARMEN GARO H		Sell	100,000	$0.95	$94.8K2.1% OS	1,866,400
May 4, 2023	ARMEN GARO H		Buy	100,000	$0.95	$94.8K2.1% OS	1,978,010
Jul 21, 2022	WIINBERG ULF	Director	Buy	20,000	$1.38	$27.6K	298,300
Oct 20, 2021	AGENUS INC	10% Owner	Buy	1,400,000	$12.00	$16.80M29.8% OS	20,881,000

INKT Insider Buying Activity

The following table shows recent insider purchases of MiNK Therapeutics, Inc. (INKT) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Oct 16, 2023	AGENUS INC		Buy	22,975	$1.10	$25.3K	21,772,864
Oct 6, 2023	AGENUS INC		Buy	15,001	$1.09	$16.4K	21,749,888
Aug 31, 2023	AGENUS INC		Buy	29,678	$1.52	$45.0K0.6% OS	21,734,888
Aug 28, 2023	AGENUS INC	10% Owner	Buy	183,052	$1.54	$281.5K3.9% OS	21,705,208
May 12, 2023	AGENUS INC		Buy	45,426	$1.47	$66.6K1.0% OS	21,640,472
May 5, 2023	AGENUS INC		Buy	250,362	$1.04	$260.2K5.3% OS	21,595,048
May 4, 2023	ARMEN GARO H		Buy	100,000	$0.95	$94.8K2.1% OS	1,978,010
Jul 21, 2022	WIINBERG ULF	Director	Buy	20,000	$1.38	$27.6K	298,300
Oct 20, 2021	AGENUS INC	10% Owner	Buy	1,400,000	$12.00	$16.80M29.8% OS	20,881,000

INKT Insider Selling Activity

The following table shows recent insider sales of MiNK Therapeutics, Inc. (INKT) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Oct 14, 2026	Buell Jennifer	director, officer: Chief Executive Officer	Sell	6,938	$10.56	$73.3K	74,195
Jun 5, 2026	Ryan Barbara	director	Sell	1,500	$12.76	$19.1K	22,969
Mar 11, 2026	Ryan Barbara	director	Sell	1,000	$14.27	$14.3K	21,706
May 5, 2023	ARMEN GARO H		Sell	100,000	$0.95	$94.8K2.1% OS	1,866,400